NR4A1 and breast cancer: Friedman et al., 24 used multivariate logistic regression to assess the probability of definitive locoregional therapy, hormone receptor testing, and adjuvant systemic therapy among 662,117 White, Black, and Hispanic women diagnosed with invasive BC during 1998–2005 at National Cancer Database hospitals.